However, quality of life considerations remain paramount, and alternative therapeutic options should be discussed if side effects significantly impair daily functioning despite comprehensive management strategies
They also provide greater convenience and adherence for those unwilling to self-inject
Sung H, Nah J, Chun S, Park H, Yang SE, Min WK
Read clinical review Clinical Reviews GIP/GLP-1 Dual Agonists: Class Overview Monograph A prescriber-level monograph covering the pharmacology, clinical trial data, dosing, safety, and approved indications for GIP/GLP-1 dual agonists, with tirzepatide as the class prototype
Pre-Filled Multi-Dose Pen: Ready-to-use for weekly injection Administration: Subcutaneous injection (abdomen, thigh, or upper arm) Weekly Protocol: Follow step-up dosing recommendations from your healthcare provider or administer to your patients based on their goals